Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 11, 2001

View Archived Issues

IND submitted for oral interferon in HIV-related oral warts

Chiron in new tobramycin collaboration with Inhale; terminates agreement with AeroGen

Procyon enters cancer technology option agreement

Pioglitazone prevents profibrogenic responses in the liver

Pharmacia outlines plans and priorities for delivering growth

Patients with refractory or relapsed acute leukemia respond to weekly BMS-214662

ICL-670A is an effective and safe iron chelator in beta-thalassemia according to preliminary data

Apoptotic effects of HA-14-1 characterized in leukemia and lymphoid cells

Full analysis of phase II data confirm efficacy of BBR-2778 in advanced NHL

FK-463 safe in stem cell transplant recipients according to ASH presentation

Immunomodulatory thalidomide derivative as a potential new therapeutic option for multiple myeloma

AC-7739 possesses cytotoxic and proapoptotic effects in MDR leukemia cell lines

Cipralex approved in Sweden; European mutual recognition procedure initiated

Cureon and Oxagen enter gene validation collaboration

Ortho-Clinical Diagnostics and Caprion to develop vCJD diagnostic test

Selective nonsteroidal estrogen receptor modulators claimed in recent patent

Takeda synthesizes oxazole-based HER2 receptor tyrosine kinase inhibitors

New HDL-elevating compounds from AtheroGenics useful in cardiovascular disease therapy

Final results of Val-HeFT study of valsartan in heart failure

GSK-3 inhibitors and use in diabetes and other disorders

Pharmacia R&D team identifies antibacterial agents particularly useful in skin and eye infections

Production and use of p38 MAP kinase inhibitors with additional pharmacological activities

FDA strengthens warnings for droperidol

Bioglan announces scheduled launch of Solaraze Gel in the U.S.

Biora licenses rights to wound healing product to Molnlycke Health Care

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.